Covered recipient · General Payments record
TONYA M RUSHING
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$710.03
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $440.81 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $189.33 | 10 |
| Acerta Pharma LLC | $154.00 | 3 |
| Neurocrine BioSciences, Inc. | $33.26 | 1 |
| Lundbeck LLC | $19.80 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.44 | 1 |
| TOLMAR, INC. | $14.76 | 1 |
| Lilly USA, LLC | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.54 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126265 | CMS |
| ABBVIE INC. | $7.37 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126267 | CMS |
| ABBVIE INC. | $117.65 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126269 | CMS |
| ABBVIE INC. | $2.00 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126271 | CMS |
| ABBVIE INC. | $7.69 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126273 | CMS |
| ABBVIE INC. | $7.94 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126275 | CMS |
| ABBVIE INC. | $19.60 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126277 | CMS |
| ABBVIE INC. | $1.87 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126279 | CMS |
| ABBVIE INC. | $20.80 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126281 | CMS |
| ABBVIE INC. | $1.87 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126283 | CMS |
| AstraZeneca Pharmaceuticals LP | $118.06 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104728657 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.37 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105897756 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.57 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104219179 | CMS |
| Lilly USA, LLC | $14.22 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135981007 | CMS |
| Lundbeck LLC | $19.80 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146084683 | CMS |
| Neurocrine Biosciences, Inc. | $33.26 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150934058 | CMS |
| Tolmar, Inc. | $14.76 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138721540 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.44 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144640334 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.